The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
The complexity of Alzheimer’s disease: an evolving puzzle
Abstract
The history of Alzheimer’s disease (AD) started in 1907, but we needed to wait until the end of the century to identify the components of pathological hallmarks and genetic subtypes and to formulate the first pathogenic hypothesis. Thanks to biomarkers and new technologies, the concept of AD then rapidly changed from a static view of an amnestic dementia of the presenium to a biological entity that could be clinically manifested as normal cognition or dementia of different types. What is clearly emerging from studies is that AD is heterogeneous in each aspect, such as amyloid composition, tau distribution, relation between amyloid and tau, clinical symptoms, and genetic background, and thus it is probably impossible to explain AD with a single pathological process. The scientific approach to AD suffers from chronological mismatches between clinical, pathological, and technological data, causing difficulty in conceiving diagnostic gold standards and in creating models for drug discovery and screening. A recent mathematical computer-based approach offers the opportunity to study AD in real life and to provide a new point of view and the final missing pieces of the AD puzzle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–260 of 260
Drug repositioning for Alzheimer’s disease based on systematic “omics” data mining
Zhang, M., Schmitt-Ulms, G., Sato, C., Xi, Z., Zhang, Y., Zhou, Y., St George-Hyslop, P., & Rogaeva, E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0168812 · Cited by 108
Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways
Duggan, S. P., & McCarthy, J. V. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.006 · Cited by 107
In vivo tau imaging: Obstacles and progress
Villemagne, V. L., & Okamura, N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.013 · Cited by 100
Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia)
Glenner, G. G. (1979) · Medical Hypotheses · doi:10.1016/0306-9877(79)90005-7 · Cited by 100
Duyckaerts, C. J., Delaère, P., Hauw, J., Abbamondi-Pinto, A. L., Sorbi, S., Allen, I. E., Brion, J., Flament-Durand, J., Duchen, L. W., Kauss, J., et al. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90226-d · Cited by 99
Self-citationBiological function of Presenilin and its role in AD pathogenesis
Zhang, S., Zhang, M., Cai, F., & Song, W. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-15 · Cited by 98
Sheffield, L. G., Marquis, J. G., & Berman, N. E. J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01037-5 · Cited by 96
Mo, J., Li, J., Yang, Z., Liu, Z., & Feng, J. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.469 · Cited by 96
Silva, M. D. F., Dias, K. S. T., Gontijo, V. S., Ortiz, C. J. C., & Viegas, C. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180111101843 · Cited by 96
Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease
Hunter, S., & Brayne, C. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.218 · Cited by 94
THE SO-CALLED “VISUAL AGNOSIAS”
Bender, M. B., & FELDMAN, M. (1972) · Brain · doi:10.1093/brain/95.1.173 · Cited by 94
Smith, A. R., Smith, R. G., Condliffe, D., Hannon, E. J., Schalkwyk, L. C., Mill, J. S., & Lunnon, K. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.008 · Cited by 92
Elevation of Peripheral BDNF Promoter Methylation Links to the Risk of Alzheimer's Disease
Chang, L. Y., Wang, Y., Ji, H., Dai, D., Xu, X., Jiang, D., Hong, Q., Ye, H., Zhang, X., Zhou, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110773 · Cited by 91
Haeberlein, S. B., O'Gorman, J. T., Chiao, P.-C., Bussière, T., von Rosenstiel, P., Tian, Y., Zhu, Y., von Hehn, C., Gheuens, S., Skordos, L., et al. (2017) · PubMed · doi:10.14283/jpad.2017.39 · Cited by 88
The Identity of Alzheimer's Disease and Senile Dementia and Their Relationship to Senility
Newton, R. (1948) · Journal of Mental Science · doi:10.1192/bjp.94.395.225 · Cited by 87
Molecular subtypes of Alzheimer’s disease
Fede, G. D., Catania, M., Maderna, E., Ghidoni, R., Benussi, L., Tonoli, E., Giaccone, G., Moda, F., Paterlini, A., Campagnani, I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21641-1 · Cited by 87
sAPPα antagonizes dendritic degeneration and neuron death triggered by proteasomal stress
Copanaki, E., Chang, S., Vlachos, A., Tschäpe, J., Müller, U., Kögel, D., & Deller, T. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.04.007 · Cited by 85
Ozaki, Y., Yoshino, Y., Yamazaki, K., Sao, T., Mori, Y., Ochi, S., Yoshida, T., Mori, T., Iga, J., & Ueno, S. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.04.003 · Cited by 85
Nagata, T., Kobayashi, N., Ishii, J., Shinagawa, S., Nakayama, R., Shibata, N., Kuerban, B., Ohnuma, T., Kondo, K., Arai, H., et al. (2015) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000375367 · Cited by 82
Pyramidal Nerve Cell Loss in Alzheimer's Disease
Mann, D. M. A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0057 · Cited by 81
In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
Tournier, B. B., Tsartsalis, S., Ceyzériat, K., Garibotto, V., & Millet, P. (2020) · Cells · doi:10.3390/cells9091941 · Cited by 79
Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
Hellström‐Lindahl, E., Viitanen, M. H., & Marutle, A. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.03.007 · Cited by 78
Advancing Alzheimer’s research: a review of big data promises
Zhang, R., Simon, G., & Yu, F. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.07.002 · Cited by 77
Novel AβIsoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment
Portelius, E., Mattsson, N., Andréasson, U., Blennow, K., & Zetterberg, H. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797416039 · Cited by 74
Neuropathology of Alzheimer's Disease
Mott, R. T., & Hulette, C. M. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.003 · Cited by 72
Focal Cortical Atrophy Syndromes
Black, S. E. (1996) · Brain and Cognition · doi:10.1006/brcg.1996.0042 · Cited by 72
MicroRNA in Alzheimer’s disease revisited: implications for major neuropathological mechanisms
Dehghani, R., Rahmani, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0042 · Cited by 72
Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer
Petra, E. S. (2012) · Frontiers in bioscience · doi:10.2741/4035 · Cited by 68
The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update
Hendrix, J. A., Finger, B., Weiner, M. W., Frisoni, G. B., Iwatsubo, T., Rowe, C. C., Kim, S. Y., Guinjoan, S. M., Sevlever, G. E., & Carrillo, M. C. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.008 · Cited by 67
Variable phenotype of Alzheimer’s disease with spastic paraparesis
Karlström, H., Brooks, W. S., Kwok, J. B., Broe, G. A., Kril, J. J., McCann, H., Halliday, G. M., & Schofield, P. R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05038.x · Cited by 67
Alzheimer's disease with spastic paresis and cotton wool type plaques
Tabira, T., Chui, D. H., Nakayama, H., Kuroda, S., & Shibuya, M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10392 · Cited by 65
Microglia in Alzheimer Brain: A Neuropathological Perspective
Mrak, R. E. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/165021 · Cited by 63
Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD
Carrasquillo, M. M., Khan, Q. U. A., Murray, M. E., Krishnan, S., Aakre, J. A., Pankratz, V. S., Nguyen, T., Ma, L., Bisceglio, G. D., Petersen, R. C., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000335 · Cited by 62
Wesenhagen, K. E. J., Teunissen, C. E., Visser, P. J., & Tijms, B. M. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1670613 · Cited by 58
Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to
Henriques, A. D., Benedet, A. L., Camargos, E. F., Rosa‐Neto, P., & Nóbrega, O. D. T. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.01.002 · Cited by 56
Xie, B., Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., & Xu, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160954 · Cited by 55
Toward a multifactorial model of Alzheimer disease
Storandt, M., Head, D. M., Fagan, A. M., Holtzman, D. M., & Morris, J. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.029 · Cited by 54
Guerreiro, R. J., Brás, J., Hardy, J., & Singleton, A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu203 · Cited by 54
In Vivo Brain Imaging of Tangle Burden in Humans
Small, G. W., Agdeppa, E. D., Kepe, V., Satyamurthy, N., Huang, S., & Barrio, J. R. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:321 · Cited by 52
ApoE E4 is a Susceptibility Factor in Amnestic But Not Aphasic Dementias
Rogalski, E. J., RADEMAKER, A. W., Harrison, T. M., Helenowski, I., Johnson, N., Bigio, E. H., Mishra, M., Weıntraub, S., & Mesulam, M. M. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318201f249 · Cited by 49
Bi, C., Bi, S., & Li, B. (2018) · Aging and Disease · doi:10.14336/ad.2018.0425 · Cited by 46
Alzheimer’s Disease Progression: Factors Influencing Cognitive Decline
Ferrari, C., Lombardi, G., Polito, C., Lucidi, G., Bagnoli, S., Piaceri, I., Nacmias, B., Berti, V., Rizzuto, D., Fratiglioni, L., et al. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170665 · Cited by 44
Self-citationLi, A., Yang, P., Taiclet, L., & Tanzi, R. E. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy414 · Cited by 43
Bastos, P. A. D., Ferreira, R. M., Manadas, B. J., Moreira, P. I., & Vitorino, R. M. P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1299682 · Cited by 40
APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort
Weıntraub, S., Teylan, M., Rader, B. M., Chan, K. C. G., Bollenbeck, M., Kukull, W. A., Coventry, C., Rogalski, E. J., Bigio, E. H., & Mesulam, M. M. (2019) · Neurology · doi:10.1212/wnl.0000000000008666 · Cited by 40
Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
Rowland, H. A., Hooper, N. M., & Kellett, K. A. B. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2663-z · Cited by 38
Does “Benign Senescent Forgetfulness” Exist?
Bamford, K. A., & Caine, E. D. (1988) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30724-9 · Cited by 37
Kunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · doi:10.1101/294629 · Cited by 35
Self-citationReimand, J., de Wilde, A., Teunissen, C. E., Zwan, M. D., Windhorst, A. D., Boellaard, R., Barkhof, F., van der Flier, W. M., Scheltens, P., van Berckel, B. N. M., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0561-5 · Cited by 31
PAIRED HELICAL FILAMENT ANTIGEN IN CSF
Mehta, P. D., Thal, L. J., Wisniewski, H. M., Grundke, I., & Iqbal, K. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90074-1 · Cited by 29
A Review of the Familial Alzheimer’s Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1
Jiang, H., Jayadev, S., Lardelli, M. T., & Newman, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180656 · Cited by 27
Chatterjee, P., Roy, D., & Rathi, N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161104 · Cited by 25
Slemmon, J. R., Shapiro, A., Mercken, M. H., Streffer, J. R., Romano, G. J., Andreasen, N., Zetterberg, H., & Blennow, K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13297 · Cited by 20
Genetic and epigenetic study of an Alzheimer’s disease family with monozygotic triplets
Zhang, M., Dilliott, A. A., Khallaf, R. A., Robinson, J. F., Hegele, R. A., Comishen, M., Sato, C., Tosto, G., Reitz, C., Mayeux, R. P., et al. (2019) · Brain · doi:10.1093/brain/awz289 · Cited by 18
Zhang, S., Lei, C., Liu, P., Zhang, M., Tao, W., Liu, H., & Liu, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.003 · Cited by 16
A Window into the Heterogeneity of Human Cerebrospinal Fluid Aβ Peptides
Ghidoni, R., Paterlini, A., Albertini, V., Stoppani, E., Binetti, G. G., Fuxé, K., Benussi, L., & Agnati, L. F. (2011) · BioMed Research International · doi:10.1155/2011/697036 · Cited by 15
Primary Progressive Aphasia: Natural History in an Italian Cohort
Ferrari, C., Polito, C., Vannucchi, S., Piaceri, I., Bagnoli, S., Lombardi, G., Lucidi, G., Berti, V., Nacmias, B., & Sorbi, S. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000282 · Cited by 15
Self-citationGenetic engineering of a mouse: Dr. Frank Ruddle and somatic cell genetics.
Jones, D. (2011) · PubMed Central · Cited by 12
Negative Amyloid PET Imaging in a Patient With Probable Alzheimer's Disease
Hellwig, S., Hüll, M., & Meyer, P. T. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182335e08 · Cited by 4
Ferrari, C., Polito, C., Berti, V., Lombardi, G., Lucidi, G., Bessi, V., Bagnoli, S., Piaceri, I., Nacmias, B., & Sorbi, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190677 · Cited by 3
Self-citation
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“174 ,175 A β also causes the formation and activation of the NLRP3 in fl ammasome within microglia, which releases ASC specks that bind rapidly to A β in promoting A β aggregates and the spread of A β pathology.”
BackgroundImmunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Song, C., Shi, J., Zhang, P., Zhang, Y., Xu, J., Zhao, L., Zhang, R., Wang, H., & Chen, H. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00292-3 · Cited by 266
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Jung, E. S., Choi, H., & Mook-Jung, I. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00825-0 · Cited by 124
Nichols, E., Merrick, R., Hay, S. I., Himali, D., Himali, J. J., Hunter, S., Keage, H. A. D., Latimer, C. S., Scott, M. R., Steinmetz, J. D., et al. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00019-3 · Cited by 108
Talar, K., Vetrovsky, T., van Haren, M., Négyesi, J., Granacher, U., Váczi, M., Martín-Arévalo, E., Del Olmo, M. F., Kałamacka, E., & Hortobágyi, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101738 · Cited by 59
Metadata
- Authors
- Ferrari, C., & Sorbi, S.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2021-07-01
- Volume
- 101
- Issue
- 3
- Pages
- 1047-1081
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W3125322711
- Cited by
- 309
- References
- 260
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.